Value investing is always a very popular strategy, and for good reason. After all, who doesn’t want to find stocks that have low PEs, solid outlooks, and decent dividends?
Fortunately for investors looking for this combination, we have identified a strong candidate which may be an impressive value; CDW Corporation (CDW - Free Report) .
CDW in Focus
CDW may be an interesting play thanks to its forward PE of 18.1 its P/S ratio of 0.9, and its decent dividend yield of 1.3%. These factors suggest that CDW is a pretty good value pick, as investors have to pay a relatively low level for each dollar of earnings, and that CDW has decent revenue metrics to back up its earnings.
CDW Corporation PE Ratio (TTM)
But before you think that CDW is just a pure value play, it is important to note that it has been seeing solid activity on the earnings estimate front as well. For current year earnings, the consensus has gone up by 1.4% in the past 30 days, thanks to five upward revisions in the past one month compared to none lower.
This estimate strength is actually enough to push CDW to a Zacks Rank #2 (Buy), suggesting it is poised to outperform. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
So really, CDW is looking great from a number of angles thanks to its PE below 20, a P/S ratio below one, and a strong Zacks Rank, meaning that this company could be a great choice for value investors at this time.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>